Funding / Entrepreneur
INVESTING Individual Investor Financial Adviser Institutional Investor FUNDING Entrepreneur Real Estate
Reading time: < 1 minute

23 Mar 2013 By Ian Perry


Antidote is a digital health company that connects sponsors of medical research with the people who need treatment. Their aim is to accelerate breakthroughs in treatments for various conditions by helping to recruit more people to vital clinical trials. Medical research can be frustratingly slow, partly due to a scarcity of eligible participants. Antidote provides a platform where sponsors can find suitable volunteers willing to play their part in advancing knowledge and treatment of their conditions.

Related articles

What next for European healthtech?
1 Sep 2023

What next for European healthtech?

Our recent report, The Resilience of Early-Stage European Healthtech, took a granular look at the sector. In this blog, Matt Vallin unpacks our predictions.
Written by Matthieu Vallin
Our Investment in Little Journey
18 Apr 2023

Our Investment in Little Journey

Read about investment in Little Journey, a digital eSupport platform that provides multi-faceted support to children and families before, during and after healthcare procedures and clinical trials.
Written by Joe Stringer